118 related articles for article (PubMed ID: 2156736)
1. Effects of the antiprogesterone RU486 in the early follicular phase of the menstrual cycle.
Stuenkel CA; Garzo VG; Morris S; Liu JH; Yen SS
Fertil Steril; 1990 Apr; 53(4):642-6. PubMed ID: 2156736
[TBL] [Abstract][Full Text] [Related]
2. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
3. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
4. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
5. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
6. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
Nippoldt TB; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
[TBL] [Abstract][Full Text] [Related]
7. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
8. The role of pre-ovulatory progesterone in the midcycle gonadotrophin surge, ovulation and subsequent luteal phase: studies with RU486 in rhesus monkeys.
Remohi J; Balmaceda JP; Rojas FJ; Asch RH
Hum Reprod; 1988 May; 3(4):431-5. PubMed ID: 3134390
[TBL] [Abstract][Full Text] [Related]
9. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
Reame NE; Kelche RP; Beitins IZ; Yu MY; Zawacki CM; Padmanabhan V
J Clin Endocrinol Metab; 1996 Apr; 81(4):1512-8. PubMed ID: 8636360
[TBL] [Abstract][Full Text] [Related]
10. Altered luteinizing hormone pulse frequency in early follicular phase of the menstrual cycle with luteal phase defect patients in women.
Suh BY; Betz G
Fertil Steril; 1993 Nov; 60(5):800-5. PubMed ID: 8224264
[TBL] [Abstract][Full Text] [Related]
11. Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase.
Shoupe D; Mishell DR; Page MA; Madkour H; Spitz IM; Lobo RA
Am J Obstet Gynecol; 1987 Dec; 157(6):1421-6. PubMed ID: 2827482
[TBL] [Abstract][Full Text] [Related]
12. Response to intermittent RU486 in women.
Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
[TBL] [Abstract][Full Text] [Related]
13. Decreased follicular phase gonadotropin secretion is associated with impaired estradiol and progesterone secretion during the follicular and luteal phases in normally menstruating women.
Schweiger U; Laessle RG; Tuschl RJ; Broocks A; Krusche T; Pirke KM
J Clin Endocrinol Metab; 1989 May; 68(5):888-92. PubMed ID: 2497129
[TBL] [Abstract][Full Text] [Related]
14. A possible dual mechanism of the anovulatory action of antiprogesterone RU486 in the rat.
Sánchez-Criado JE; Bellido C; Galiot F; López FJ; Gaytán F
Biol Reprod; 1990; 42(5-6):877-86. PubMed ID: 2116924
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
[TBL] [Abstract][Full Text] [Related]
16. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition.
Hall JE; Schoenfeld DA; Martin KA; Crowley WF
J Clin Endocrinol Metab; 1992 Mar; 74(3):600-7. PubMed ID: 1740493
[TBL] [Abstract][Full Text] [Related]
18. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
19. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[TBL] [Abstract][Full Text] [Related]
20. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
Schipper I; Hop WC; Fauser BC
J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]